HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 hyex_ex10z1.htm SECURITIES PURCHASE AGREEMENT DATED JULY 17, 2026 Securities Purchase Agreement (Fire-Ubiquity) (00346656-5).DOCX SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2026, by and between Healthy Extrac

Event · Offering
Instrument
Promissory Note
Gross proceeds
$258,750
Maturity
a maturity date of one year

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Jul 23, 2026, 9:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 10:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HYEX
Neutral
medium confidence
Mentioned
$HYEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HYEXNeutralMed
01

Why it matters

A new convertible note financing can create an overhang through expected dilution and potential selling pressure if the holder converts and liquidates shares. Traders will focus on conversion terms and any subsequent amendments or registration statements.

02

Market read

Convertible note financing is newly disclosed and can affect valuation via dilution expectations, even without immediate cash-flow guidance.

03

What to watch

Key trading drivers are missing from the excerpt: conversion price/ratio, maturity, interest rate, any beneficial ownership changes, and whether the buyer has registration rights or intends to convert/sell quickly.

Relevance 6/10Novelty 6/10Timing: after-hours SEC 8-K filing dated July 23, 2026

Background

The 8-K reports entry into a material definitive agreement, specifically a securities purchase agreement for a convertible promissory note under Rule 506(b).

Company-level read

Ticker impact

$HYEXNeutralMedium confidence
Context

Healthy Extracts Inc. entered a securities purchase agreement to issue a $258,750 convertible promissory note to LABRYS Fund II.

Expected impact

Near-term bias depends on conversion price/beneficial ownership details not included in the excerpt; expect potential dilution over time.

Evidence & confidence

This is a primary 8-K disclosure of a capital raise instrument (convertible note). The excerpt provides principal and purchase price but not conversion mechanics, so directionality is uncertain.

Market effects

Microcap/small-cap financing via convertible notes can signal ongoing funding needs in the specialty extracts/biotech-adjacent space.

No clear regional spillover indicated by the filing excerpt.

Limited global relevance; this appears company-specific capital raising.

Counterpoint

If the conversion terms are favorable to the company (higher conversion price, limited discount, or capped dilution), the note could be less overhang than typical convertibles.

Key entities

  • Healthy Extracts Inc.

    Nevada corporation that issued the convertible promissory note under the securities purchase agreement.

  • LABRYS Fund II, L.P.

    Accredited investor purchasing the note for $225,000, with fee withholdings described in the agreement.

  • Carter, Terry, & Company, Inc.

    Registered broker-dealer referenced as receiving a fee from the purchase price.

Related articles

$ITGRMed

Integer noteholders receive conversion terms following merger

Integer Holdings Corporation completed its merger with Armstrong Bidco Inc., triggering conversion rights for holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030. Noteholders can convert their securities until January 8, 2027, receiving enhanced rates during the make-whole period. The company is not required to repurchase the notes due to the merger's cash-only nature.